MSD
The Principal Scientist will lead drug metabolism and pharmacokinetic (DMPK) efforts for peptide and protein therapeutics across immunology and oncology programs, collaborating with multi‑disciplinary discovery teams in Boston and other sites. The role involves designing and interpreting ADME, PK, and PK/PD studies, contributing to global DMPK strategy, and representing the PDMB group on cross‑functional projects.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
Right around the average for this role
MSD ends takeover talks with Revolution Medicines
1 month ago
Principal Scientist (Director-Level Equivalent)
Merck & Co., Inc.
Senior Principal Scientist
Merck & Co., Inc.
Principal Scientist, Drug Metabolism and Pharmacokinetics
alnylam
Senior Director, Pharmacokinetics, Dynamics, Metabolism and Bioanalytics (PDMB)
Merck & Co., Inc.
Principal Scientist in DMPK
Merck & Co., Inc.
Senior Director, DMPK Project Leader
Eli Lilly and Company